Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

DEM — Predicate Candidate Screening

30 FDA 510(k) clearances under this product code; the 50 most recent screened below.

80 daysmedian FDA review time
209 days90th percentile
30clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K123256HUMAN ALPHA-1 ANTITRYPSIN KIT SPAPLUSThe Binding Site Group , Ltd.2013-07-032580
K063610DIMENSION VISTA A1AT FLEX REAGENT CARTRIDGE AND PROTEIN 1 CADade Behring, Inc.2007-01-11380
K053072N ANTISERA TO HUMAN ALPHA1-ANTITRYPSINDade Behring, Inc.2006-03-281470
K052819VITROS CHEMISTRY PRODUCTS AAT REAGENT, CALIBRATOR KIT 99 ANDOrtho-Clinical Diagnostics, Inc.2005-12-23800
K050596QUANTIA A1-ATBiokit, S.A.2005-05-13660
K031857ADVIA CHEMISTRY ALPHA-1 ANTITRYPSIN ASSAYBayer Diagnostics Corp.2003-09-04800
K011663MININEPH A-1 ANTITRYPSIN ANTISERUM, HIGH AND LOW SERUM CONTRThe Binding Site, Ltd.2001-07-30620
K010978TINA-QUANT ALPHA-1 ANTITRYPSINRochdiag2001-05-18660
K993444K-ASSAY ALPHA-1 ATKamiya Biomedical Co.1999-11-24430
K972640TINA-QUANT ALPHA PARTICLE-1-ANTITRYPSIN ASSAYBoehringer Mannheim Corp.1998-01-091780
K973389CHEMMATE UCHL1 (CD45RO) PREDILUTED ANTIBODY FOR IMMUNOHISTOCVentana Medical Systems, Inc.1997-10-03850
K973392CHEMMATE LAMBDAVentana Medical Systems, Inc.1997-10-03860
K973391CHEMMATE KAPPAVentana Medical Systems, Inc.1997-10-03850
K973390CHEMMATE L26 (CD20)Ventana Medical Systems, Inc.1997-10-03850
K965100N-ASSAY TIA ALPHA-1-ANTITRYPSIN TEST KITCrestat Diagnostics, Inc.1997-07-142061
K964766IMMAGE IMMUNOCHEMISTRY SYSTEM ALPHA-1-ANTITRYPSIN (AAT)Beckman Instruments, Inc.1997-04-251490
K931979VENTANA NEGATIVE CONTROL REAGENTVentana Medical Systems, Inc.1994-03-303420
K920005IL TEST ALPHA-1-ANTITRYPSIN (AAT)Instrumentation Laboratory CO1992-07-292090
K913666ALPHA-1-ANTITRYPSIN IMMUNOLOGICAL NL TEST KITThe Binding Site, Ltd.1991-12-091120
K890415SPQ(TM) ANTIBODY REAGENT SET II FOR AATAtlantic Antibodies1989-02-17240
K882446ALPHA1ANTITRYPSIN FOR TECHNICON DPA-1(TM) SYSTEMTechnicon Instruments Corp.1988-07-08240
K875283QM2/QM300 CONTROL B PACKKallestad Diag, A Div. of Erbamont, Inc.1988-02-10480
K875281QM300 ALPHA1-ANTITRYPSIN ANTIBODY PACKKallestad Diag, A Div. of Erbamont, Inc.1988-02-10480
K850587SPQ TEST SYSTEM FOR ALPHA, - ANTITRYPSINApplications Lab1985-03-14290
K801669J.T. BAKER ALPHA-1-ANTITRYPSIN NEPHELOJ.T. Baker Chemical Co.1980-09-16560
K791605GOAT ANTI-HUMAN ALPHA-1-ANTITRYPSINProtos Laboratories1979-09-04150
K781408RID SYSTEM-(ACP) TESTIcl Scientific1978-08-2170
K772080RADIAL IMMUNODIFFUSION KIT-ALPH-L-ANTITGelman Instrument Co.1978-02-03920
K760916LAS-R HUMAN ALPHA, ANTITRYPSIN TESTHyland Therapeutic Div., Travenol Laboratories1976-11-16190
K760034TEST, STREP, LATEX SLIDEGamma Biologicals, Inc.1976-08-11580

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda